Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid-related orphan receptor gamma (RORγ) is a nuclear receptor transcription factor that plays a crucial role in immune system development, circadian rhythm regulation, and metabolic functions. It is essential for Th17 cell differentiation and IL-17 production, making it a key target for autoimmune diseases. RORγ also regulates genes involved in lipid and carbohydrate metabolism, impacting metabolic disorders. The protein possesses a DNA-binding domain and a ligand-binding domain that can be targeted by agonists and inverse agonists to modulate its activity. Its expression is widespread, including immune cells, liver, adipose tissue, skeletal muscle, and kidney.
Agonist or inverse agonist binding to the ligand-binding domain, modulating transcriptional activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid-related orphan receptor gamma (RORγ).